Clarification of Terms and Conditions of Awards using Human Embryonic Stem Cells

Notice Number: NOT-OD-10-029

Key Dates
Release Date: December 14, 2009

Other Relevant Notices

Issued by
National Institutes of Health (NIH), (

NIH is now approving human embryonic stem cell lines (hESCs) under the NIH Guidelines for Human Stem Cell Research.  Approved lines appear on the NIH Human Embryonic Stem Cell Registry.

Applicants and grantees interested in using approved hESCs should view the Details for lines of interest (link in the far left column at:  In the table "Detailed information for selected cell line" there may be restrictions that apply to the specific line.  These are limitations that are placed on the use of the hESC by the provider of the line or by NIH.  For example, the provider may restrict the use of the line to noncommercial use only.  There may also be limitations due to specific language in the informed consent.   Accordingly, grantees must honor all restrictions when using the line.

NIH will place a term on all hESC awards indicating that the grantee may only use those hESCs that appear on the NIH Human Embryonic Stem Cell Registry as eligible for NIH funding, and in accord with any restrictions placed on the use of those lines.

Additional Information
For additional information see:


Inquiries should be directed to:

Division of Grants Policy
Office of Policy for Extramural Research Administration
National Institutes of Health
6705 Rockledge Drive, Suite 350
Bethesda, MD 20892

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.